Table 2.
Conventional laboratory assays of the study population (n = 70).
| Variables | With Persistent Infection (n = 6) |
Without Persistent Infection (n = 64) |
p-Value |
|---|---|---|---|
| PLTs (×103/mL) | 261.8 ± 58.1; 264.0 (216.0–295.0) |
270.1 ± 43.4; 271.0 (238.0–298.0) |
0.67 |
| aPTT (s) | 33.1 ± 3.8; 32.5 (30.0–34.0) | 32.3 ± 4.9; 32.0 (30.0–34.2) | 0.58 |
| PT (s) | 13.1 ± 2.0; 13.5 (12.0–14.0) | 12.5 ± 2.1; 12.3 (11.7–14.0) | 0.46 |
| D-dimers (mg/L) | 0.6 ± 0.3; 0.8 (0.5–0.9) | 0.6 ± 0.7; 0.4 (0.1–0.8) | 0.29 |
| Fibrinogen (mg/dL) | 415.0 ± 73.7; 413.0 (348.0–476.0) |
334.0 ± 79.2; 330.0 (293.5–380.0) |
0.029 |
| CRP (mg/L) | 5.5 ± 0.6; 5.4 (5.2–6.2) | 12.1 ± 15.9; 3.9 (3.3–17.0) | 0.31 |
| ESR (mm/h) | 12.6 ± 6.9; 15.5 (4.0–17.0) | 12.2 ± 12.5; 12.0 (2.30–18.0) | 0.38 |
Data are presented as mean ± SD or median and interquartile range (IQR). The nonparametric Wilcoxon rank-sum test was used for comparison between groups. Abbreviations: PLTs, platelets; aPTT, activated partial thromboplastin time; PT, prothrombin time; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate. Bold indicates statistical significance at p value < 0.05.